The gp49B1 inhibitory receptor regulates the IFN-γ responses of T cells and NK cells

Journal of Immunology

Volumn 170, Issue 8, 2003, Pages 4095-4101

  Gu, Xiaogang ^a   Laouar, Amale ^a   Wan, Junmei ^a   Daheshia, Massoud ^a,b   Lieberman, Judy ^a   Yokoyama, Wayne M ^c   Katz, Howard R ^a,b   Manjunath N, ^a  

^a HARVARD MEDICAL SCHOOL   (United States)

^b BRIGHAM AND WOMEN S HOSPITAL   (United States)

^c WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CELL RECEPTOR; GAMMA INTERFERON; GP49B1 INHIBITORY RECEPTOR; T LYMPHOCYTE RECEPTOR; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; BACTERIAL INFECTION; CELL ACTIVATION; CELL FUNCTION; CELL LINEAGE; CONTROLLED STUDY; CYTOTOXICITY; EFFECTOR CELL; INTERFERON PRODUCTION; MOUSE; NATURAL KILLER CELL; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; T LYMPHOCYTE; TUMOR IMMUNITY; VACCINIA VIRUS; VIRUS INFECTION;

EID: 0037446660     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.170.8.4095     Document Type: Article

References (44)

1. + T cells. Curr. Opin. Immunol. 13:465.
2. Raulet, D. H., R. E. Vance, and C. W. McMahon. 2001. Regulation of the natural killer cell receptor repertoire. Annu. Rev. Immunol. 19:291.
3. Mingari, M. C., C. Vitale, A. Cambiaggi, F. Schiavetti, G. Melioli, S. Ferrini, and A. Poggi. 1995. Cytolytic T lymphocytes displaying natural killer (NK)-like activity: expression of NK-related functional receptors for HLA class I molecules (p58 and CD94) and inhibitory effect on the TCR-mediated target cell lysis or lymphokine production. Int. Immunol. 7:697.
4. Noppen, C., C. Schaefer, P. Zajac, A. Schutz, T. Kocher, J. Kloth, M. Heberer, M. Colonna, G. De Libero, and G. C. Spagnoli. 1998. C-type lectin-like receptors in peptide-specific HLA class I-restricted cytotoxic T lymphocytes: differential expression and modulation of effector functions in clones sharing identical TCR structure and epitope specificity. Eur. J. Immunol. 28:1134.
5. Le Drean, E., F. Vely, L. Olcese, A. Cambiaggi, S. Guia, G. Krystal, N. Gervois, A. Moretta, F. Jotereau, and E. Vivier. 1998. Inhibition of antigen-induced T cell response and antibody-induced NK cell cytotoxicity by NKG2A: association of NKG2A with SHP-1 and SHP-2 protein-tyrosine phosphatases. Eur. J. Immunol. 28:264.
6. Speiser, D. E., M. J. Pittet, D. Valmori, R. Dunbar, D. Rimoldi, D. Lienard, H. R. MacDonald, J. C. Cerottini, V. Cerundolo, and P. Romero. 1999. In vivo expression of natural killer cell inhibitory receptors by human melanoma-specific cytolytic T lymphocytes. J. Exp. Med. 190:775.
7. De Maria, A., A. Ferraris, M. Guastella, S. Pilia, C. Cantoni, L. Polero, M. C. Mingari, D. Bassetti, A. S. Fauci, and L. Moretta. 1997. Expression of HLA class I-specific inhibitory natural killer cell receptors in HIV-specific cytolytic T lymphocytes: impairment of specific cytolytic functions. Proc. Natl. Acad. Sci. USA 94:10285.
8. Sirianni, M. C., F. Ensoli, C. Alario, V. Fiorelli, G. Sacco, S. Topino, F. Iebba, I. Mezzaroma, and F. Aiuti. 2001. Distribution of the natural killer-related receptor for HLA-C during highly active antiretroviral therapy for human immunodeficiency virus infection. Hum. Immunol. 62:1328.
9. Galiani, M. D., E. Aguado, R. Tarazona, P. Romero, I. Molina, M. Santamaria, R. Solana, and J. Pena. 1999. Expression of killer inhibitory receptors on cytotoxic cells from HIV-1-infected individuals. Clin. Exp. Immunol. 115:472.
10. Costa, P., S. Rusconi, D. Mavilio, M. Fogli, G. Murdaca, D. Pende, M. C. Mingari, M. Galli, L. Moretta, and A. De Maria. 2001. Differential disappearance of inhibitory natural killer cell receptors during HAART and possible impairment of HIV-1-specific CD8 cytotoxic T lymphocytes. AIDS 15:965.
11. De Maria, A., and L. Moretta. 2000. HLA-class I-specific inhibitory receptors in HIV-1 infection. Hum. Immunol. 61:74.
12. + T-cell clones in HIV-1 infection. Immunol Lett 72:179.
13. + T cell responses. Nat. Immunol. 3:189.
14. + T cells expressing NK cell receptors in influenza A virus-infected mice. J. Immunol. 165:4964.
15. + T cells. J. Immunol. 164:2009.
16. + T cells. J. Immunol. 169:693.
17. + T cells. J. Immunol. 169:1444.
18. Castells, M. C., X. Wu, J. P. Arm, K. F. Austen, and H. R. Katz. 1994. Cloning of the gp49B gene of the immunoglobulin superfamily and demonstration that one of its two products is an early-expressed mast cell surface protein originally described as gp49. J. Biol. Chem. 269:8393.
19. McCormick, M. J., M. C. Castells, K. F. Austen, and H. R. Katz. 1999. The gp49A gene has extensive sequence conservation with the gp49B gene and provides gp49A protein, a unique member of a large family of activating and inhibitory receptors of the immunoglobulin superfamily. Immunogenetics 50:286.
20. Wang, L. L., D. T. Chu, A. O. Dokun, and W. M. Yokoyama. 2000. Inducible expression of the gp49B inhibitory receptor on NK cells. J. Immunol. 164:5215.
21. Lee, K. H., M. Ono, M. Inui, T. Yuasa, and T. Takai. 2000. Stimulatory function of gp49A, a murine Ig-like receptor, in rat basophilic leukemia cells. J. Immunol. 165:4970.
22. Lu-Kuo, J. M., D. M. Joyal, K. F. Austen, and H. R. Katz. 1999. gp49B1 inhibits IgE-initiated mast cell activation through both immunoreceptor tyrosine-based inhibitory motifs, recruitment of src homology 2 domain-containing phosphatase-1, and suppression of early and late calcium mobilization. J. Biol. Chem. 274:5791.
23. Daheshia, M., D. S. Friend, M. J. Grusby, K. F. Austen, and H. R. Katz. 2001. Increased severity of local and systemic anaphylactic reactions in gp49B1-deficient mice. J. Exp. Med. 194:227.
24. Manjunath, N., P. Shankar, J. Wan, W. Weninger, M. A. Crowley, K. Hieshima, T. A. Springer, X. Fan, H. Shen, J. Lieberman, and U. H. von Andrian. 2001. Effector differentiation is not prerequisite for generation of memory cytotoxic T lymphocytes. J. Clin. Invest. 108:871.
25. Pircher, H., K. Burki, R. Lang, H. Hengartner, and R. M. Zinkernagel. 1989. Tolerance induction in double specific T-cell receptor transgenic mice varies with antigen. Nature 342:559.
26. Katz, H. R., E. Vivier, M. C. Castells, M. J. McCormick, J. M. Chambers, and K. F. Austen. 1996. Mouse mast cell gp49B1 contains two immunoreceptor tyrosine-based inhibition motifs and suppresses mast cell activation when coligated with the high-affinity Fc receptor for IgE. Proc. Natl. Acad. Sci. USA 93:10809.
27. Manjunath, N., M. Correa, M. Ardman, and B. Ardman. 1995. Negative regulafion of T-cell adhesion and activation by CD43. Nature 377:535.
28. + effector T cell differentiation in vivo. Proc. Natl. Acad. Sci. USA 96:13932.
29. Harrington, L. E., M. Galvan, L. G. Baum, J. D. Altman, and R. Ahmed. 2000. Differentiating between memory and effector CD8 T cells by altered expression of cell surface O-glycans. J. Exp. Med. 191:1241.
30. + T cells upon in vivo stimulation with allogeneic tumor. J. Immunol. 159:650.
31. Bertone, S., F. Schiavetti, R. Bellomo, C. Vitale, M. Ponte, L. Moretta, and M. C. Mingari. 1999. Transforming growth factor-β-induced expression of CD94/NKG2A inhibitory receptors in human T lymphocytes. Eur. J. Immunol. 29:23.
32. + T lymphocyte subsets that express HLA class I-specific inhibitory receptors represent oligoclonally or monoclonally expanded cell populations. Proc. Natl. Acad. Sci. USA 93:12433.
33. + T cells coexpressing the inhibitory major histocompatibility complex class I receptor Ly49G2. J. Virol. 74:7032.
34. Rajagopalan, S., J. Fu, and E. O. Long. 2001. Cutting edge: induction of IFN-γ production but not cytotoxicity by the killer cell Ig-like receptor KIR2DL4 (CD158d) in resting NK cells. J. Immunol. 167:1877.
35. Chuang, S. S., P. R. Kumaresan, and P. A. Mathew. 2001. 2B4 (CD244)-mediated activation of cytotoxicity and IFN-γ release in human NK cells involves distinct pathways. J. Immunol. 167:6210.
36. 3 interaction inhibits antigen-induced mast cell activation. Nat. Immunol. 2:436.
37. Zajac, A. J., R. E. Vance, W. Held, D. J. Sourdive, J. D. Altman, D. H. Raulet, and R. Ahmed. 1999. Impaired anti-viral T cell responses due to expression of the Ly49A inhibitory receptor. J. Immunol. 163:5526.
38. + T cells specific for melanocyte differentiation antigens expresses killer inhibitory receptors (KIR) in healthy donors: evidence for a role of KIR in the control of peripheral tolerance. Eur. J. Immunol. 30:1665.
39. Fahlen, L., L. Oberg, T. Brannstrom, N. K. Khoo, U. Lendahl, and C. L. Sentman. 2000. Ly49A expression on T cells alters T cell selection. Int. Immunol. 12:215.
40. Pauza, M., K. M. Smith, H. Neal, C. Reilly, L. L. Lanier, and D. Lo. 2000. Transgenic expression of Ly-49A in thymocytes alters repertoire selection. J. Immunol. 164:884.
41. Kim, S. K., M. A. Brehm, R. M. Welsh, and L. K. Selin. 2002. Dynamics of memory T cell proliferation under conditions of heterologous immunity and bystander stimulation. J. Immunol. 169:90.
42. Brehm, M. A., A. K. Pinto, K. A. Daniels, J. P. Schneck, R. M. Welsh, and L. K. Selin. 2002. T cell immunodominance and maintenance of memory regulated by unexpectedly cross-reactive pathogens. Nat. Immunol. 3:627.
43. + T cells. Nat. Immunol. 2:430.
44. Young, N. T., M. Uhrberg, J. H. Phillips, L. L. Lanier, and P. Parham. 2001. Differential expression of leukocyte receptor complex-encoded Ig-like receptors correlates with the transition from effector to memory CTL. J. Immunol. 166:3933.